- Home
- IVDA vs CVKD Comparison
IVDA vs CVKD Comparison
Compare IVDA & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- CVKD
- Stock Information
- Founded
- IVDA 2003
- CVKD 2022
- Country
- IVDA United States
- CVKD United States
- Employees
- IVDA N/A
- CVKD N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- IVDA Technology
- CVKD Health Care
- Exchange
- IVDA Nasdaq
- CVKD Nasdaq
- Market Cap
- IVDA 6.7M
- CVKD 29.5M
- IPO Year
- IVDA N/A
- CVKD 2023
- Fundamental
- Price
- IVDA $2.12
- CVKD $12.80
- Analyst Decision
- IVDA
- CVKD Strong Buy
- Analyst Count
- IVDA 0
- CVKD 1
- Target Price
- IVDA N/A
- CVKD $32.00
- AVG Volume (30 Days)
- IVDA 105.5K
- CVKD 32.3K
- Earning Date
- IVDA 08-13-2025
- CVKD 08-06-2025
- Dividend Yield
- IVDA N/A
- CVKD N/A
- EPS Growth
- IVDA N/A
- CVKD N/A
- EPS
- IVDA N/A
- CVKD N/A
- Revenue
- IVDA $7,148,449.00
- CVKD N/A
- Revenue This Year
- IVDA $340.48
- CVKD N/A
- Revenue Next Year
- IVDA N/A
- CVKD N/A
- P/E Ratio
- IVDA N/A
- CVKD N/A
- Revenue Growth
- IVDA 54.15
- CVKD N/A
- 52 Week Low
- IVDA $1.27
- CVKD $5.70
- 52 Week High
- IVDA $8.05
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- IVDA 52.04
- CVKD 49.60
- Support Level
- IVDA $1.76
- CVKD $11.00
- Resistance Level
- IVDA $2.20
- CVKD $13.71
- Average True Range (ATR)
- IVDA 0.17
- CVKD 1.14
- MACD
- IVDA 0.03
- CVKD 0.10
- Stochastic Oscillator
- IVDA 79.59
- CVKD 63.54
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.